Thermo Fisher Scientific (TMO) – Investment Analysts’ Recent Ratings Updates

A number of firms have modified their ratings and price targets on shares of Thermo Fisher Scientific (NYSE: TMO) recently:

• 10/13/2026 – Thermo Fisher Scientific had its price target raised by TD Cowen from $675.00 to $760.00. They now have a “buy” rating on the stock.
• 10/12/2026 – Thermo Fisher Scientific had its price target raised by Morgan Stanley from $650.00 to $730.00. They now have an “overweight” rating on the stock.
• 10/8/2026 – Thermo Fisher Scientific was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 10/7/2026 – Thermo Fisher Scientific had its price target raised by Barclays PLC from $650.00 to $750.00. They now have an “overweight” rating on the stock.
• 10/3/2026 – Thermo Fisher Scientific was upgraded by Wall Street Zen from “hold” to “buy”.
• 9/25/2026 – Thermo Fisher Scientific had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $720.00 price target on the stock.
• 9/12/2026 – Thermo Fisher Scientific was downgraded by Wall Street Zen from “buy” to “hold”.
• 9/9/2026 – Thermo Fisher Scientific is now covered by Piper Sandler. They set an “overweight” rating on the stock.
• 9/9/2026 – Thermo Fisher Scientific is now covered by Scotiabank. They set an “outperform” rating on the stock.
• 9/9/2026 – Thermo Fisher Scientific was downgraded by BMO Capital Markets to “market perform”.
• 9/9/2026 – Thermo Fisher Scientific was downgraded by Wells Fargo & Company from “overweight” to “underweight”.
• 9/9/2026 – Thermo Fisher Scientific was downgraded by Citigroup Inc. from “buy” to “underperform”.
• 9/9/2026 – Thermo Fisher Scientific was downgraded by Deutsche Bank Aktiengesellschaft from “buy” to “hold”.
• 9/8/2026 – Thermo Fisher Scientific was upgraded by UBS Group AG from “neutral” to “buy”. They now have a $730.00 price target on the stock, up from $540.00.
• 9/3/2026 – Thermo Fisher Scientific is now covered by CLSA. They set an “outperform” rating and a C$748.00 price target on the stock.
• 9/3/2026 – Thermo Fisher Scientific is now covered by CLSA. They set a “moderate buy” rating and a C$748.00 price target on the stock.
• 9/1/2026 – Thermo Fisher Scientific was upgraded by HSBC Holdings plc from “hold” to “strong-buy”.
• 8/28/2026 – Thermo Fisher Scientific was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.

Insider Buying and Selling

In other news, CAO Joseph Holmes sold 420 shares of the firm’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $584.81, for a total transaction of $245,620.20. Following the completion of the transaction, the chief accounting officer directly owned 2,966 shares in the company, valued at $1,734,546.46. This trade represents a 12.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Shafer sold 25,500 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $600.00, for a total value of $15,300,000.00. Following the completion of the transaction, the executive vice president directly owned 20,994 shares in the company, valued at approximately $12,596,400. This represents a 54.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 73,768 shares of company stock worth $44,122,820. Corporate insiders own 0.33% of the company’s stock.

Thermo Fisher Scientific Inc is a global provider of laboratory products, analytical instruments, reagents, consumables, software and services. Its offerings support research, drug discovery and development, clinical diagnostics, biotechnology and pharmaceutical manufacturing, as well as environmental, industrial and other applied markets.

The company’s portfolio includes mass spectrometers, genetic analysis and sequencing systems, electron microscopes, chromatography equipment, laboratory plastics, cell culture products, antibodies, protein and molecular biology reagents, and diagnostic testing solutions.